Results 11 to 20 of about 335,332 (300)

Atherogenic dyslipidemia

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C).
C N Manjunath   +3 more
doaj   +3 more sources

Diabetes Dyslipidemia [PDF]

open access: yesDiabetes Therapy, 2016
Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. Dyslipidemia is common in diabetes and there is strong evidence that cholesterol lowering improves cardiovascular ...
Schofield, Jonathan D   +4 more
openaire   +2 more sources

A novel ultrafast-low-dose computed tomography protocol allows concomitant coronary artery evaluation and lung cancer screening [PDF]

open access: yes, 2018
BACKGROUND:Cardiac computed tomography (CT) is often performed in patients who are at high risk for lung cancer in whom screening is currently recommended.
Bandiera, A   +10 more
core   +1 more source

Editorial: Secondary Dyslipidemias [PDF]

open access: yesThe Open Cardiovascular Medicine Journal, 2011
The term “secondary dyslipidemias” is used to describe the quantitative and/or qualitative alterations in lipoprotein metabolism that complicate the course of other medical disorders. Although the precise prevalence of secondary dyslipidemias has not been determined, the increasing incidence of the conditions that predispose to their development (such ...
Elisaf, M. S., Tsimihodimos, V.
openaire   +3 more sources

Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges

open access: yesItalian Journal of Pediatrics, 2022
Background It is now well established that atherosclerosis begins in childhood and evolves through adolescence and young adulthood, ultimately resulting in myocardial infarction and stroke in adults.
Giuseppe Banderali   +5 more
doaj   +1 more source

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus [PDF]

open access: yes, 2013
Purpose: This paper reports the results of an audit that assessed the prevalence of residual hypertriglyceridemia and the potential need for intensified management among patients with statin-treated type 2 diabetes mellitus (T2DM) in primary care in the ...
Feher, Michael D.   +2 more
core   +1 more source

Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism

open access: yesCardiovascular Diabetology, 2018
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9), a major regulator of cholesterol homeostasis, is associated with glucose metabolism. Liraglutide, a glucagon-like peptide-1 receptor agonist, can increase insulin secretion in a glucose ...
Sheng-Hua Yang   +13 more
doaj   +1 more source

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease

open access: yesJournal of Translational Medicine, 2018
Background Patients with monogenic familial hypercholesterolemia (FH) have high risk for coronary artery disease (CAD). A recent FH Expert Panel suggested that FH was underdiagnosed and undertreated which needs early diagnosis.
Ye-Xuan Cao   +12 more
doaj   +1 more source

Relation between cost of drug treatment and body mass index in people with type 2 diabetes in Latin America [PDF]

open access: yes, 2017
Aims Despite the frequent association of obesity with type 2 diabetes (T2D), the effect of the former on the cost of drug treatment of the latest has not been specifically addressed.
Enzo Rucci   +5 more
core   +2 more sources

The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. [PDF]

open access: yes, 2015
BackgroundPancreatic cancer has poor prognosis and existing interventions provide a modest benefit. Statin has anti-cancer properties that might enhance survival in pancreatic cancer patients.
Cook-Wiens, Galen   +6 more
core   +9 more sources

Home - About - Disclaimer - Privacy